Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2017 2
2018 2
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.
Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. Eissa IR, et al. Among authors: ichinose t. Cancers (Basel). 2018 Sep 26;10(10):356. doi: 10.3390/cancers10100356. Cancers (Basel). 2018. PMID: 30261620 Free PMC article. Review.
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer.
Hirooka Y, Kasuya H, Ishikawa T, Kawashima H, Ohno E, Villalobos IB, Naoe Y, Ichinose T, Koyama N, Tanaka M, Kodera Y, Goto H. Hirooka Y, et al. Among authors: ichinose t. BMC Cancer. 2018 May 25;18(1):596. doi: 10.1186/s12885-018-4453-z. BMC Cancer. 2018. PMID: 29801474 Free PMC article. Clinical Trial.
Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth.
Wu Z, Ichinose T, Naoe Y, Matsumura S, Villalobos IB, Eissa IR, Yamada S, Miyajima N, Morimoto D, Mukoyama N, Nishikawa Y, Koide Y, Kodera Y, Tanaka M, Kasuya H. Wu Z, et al. Among authors: ichinose t. Mol Ther Oncolytics. 2019 May 13;13:107-115. doi: 10.1016/j.omto.2019.04.004. eCollection 2019 Jun 28. Mol Ther Oncolytics. 2019. PMID: 31193737 Free PMC article.
Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials.
Eissa IR, Naoe Y, Bustos-Villalobos I, Ichinose T, Tanaka M, Zhiwen W, Mukoyama N, Morimoto T, Miyajima N, Hitoki H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. Eissa IR, et al. Among authors: ichinose t. Front Oncol. 2017 Jul 14;7:149. doi: 10.3389/fonc.2017.00149. eCollection 2017. Front Oncol. 2017. PMID: 28770166 Free PMC article. Review.
Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity.
Hotta Y, Kasuya H, Bustos I, Naoe Y, Ichinose T, Tanaka M, Kodera Y. Hotta Y, et al. Among authors: ichinose t. Oncolytic Virother. 2017 Mar 13;6:31-38. doi: 10.2147/OV.S127179. eCollection 2017. Oncolytic Virother. 2017. PMID: 28331843 Free PMC article.
Combination therapy of oncolytic herpes simplex virus HF10 and bevacizumab against experimental model of human breast carcinoma xenograft.
Tan G, Kasuya H, Sahin TT, Yamamura K, Wu Z, Koide Y, Hotta Y, Shikano T, Yamada S, Kanzaki A, Fujii T, Sugimoto H, Nomoto S, Nishikawa Y, Tanaka M, Tsurumaru N, Kuwahara T, Fukuda S, Ichinose T, Kikumori T, Takeda S, Nakao A, Kodera Y. Tan G, et al. Among authors: ichinose t. Int J Cancer. 2015 Apr 1;136(7):1718-30. doi: 10.1002/ijc.29163. Epub 2014 Sep 27. Int J Cancer. 2015. PMID: 25156870 Free article.
Feedback